5.80
price down icon3.97%   -0.24
after-market After Hours: 5.70 -0.10 -1.72%
loading
Vir Biotechnology Inc stock is traded at $5.80, with a volume of 1.18M. It is down -3.97% in the last 24 hours and up +13.06% over the past month. Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.
See More
Previous Close:
$6.04
Open:
$6.005
24h Volume:
1.18M
Relative Volume:
0.90
Market Cap:
$805.72M
Revenue:
$62.04M
Net Income/Loss:
$-533.34M
P/E Ratio:
-1.4796
EPS:
-3.92
Net Cash Flow:
$-473.07M
1W Performance:
+1.22%
1M Performance:
+13.06%
6M Performance:
+9.85%
1Y Performance:
-20.98%
1-Day Range:
Value
$5.73
$6.105
1-Week Range:
Value
$5.52
$6.38
52-Week Range:
Value
$4.155
$14.45

Vir Biotechnology Inc Stock (VIR) Company Profile

Name
Name
Vir Biotechnology Inc
Name
Phone
415-906-4324
Name
Address
1800 OWENS STREET, SAN FRANCISCO, CA
Name
Employee
408
Name
Twitter
@Vir_Biotech
Name
Next Earnings Date
2024-10-31
Name
Latest SEC Filings
Name
VIR's Discussions on Twitter

Compare VIR with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
VIR
Vir Biotechnology Inc
5.80 839.06M 62.04M -533.34M -473.07M -3.92
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
407.79 106.37B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
460.46 59.90B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
564.63 60.40B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
796.92 49.56B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
320.10 36.88B 4.56B -176.77M 225.30M -1.7177

Vir Biotechnology Inc Stock (VIR) Upgrades & Downgrades

Date Action Analyst Rating Change
Sep-03-25 Initiated Evercore ISI Outperform
Aug-27-25 Upgrade BofA Securities Neutral → Buy
Jan-29-24 Downgrade JP Morgan Overweight → Neutral
Sep-08-23 Downgrade BofA Securities Buy → Neutral
Mar-06-23 Upgrade JP Morgan Neutral → Overweight
Feb-21-23 Upgrade Goldman Neutral → Buy
Jan-27-23 Upgrade Morgan Stanley Underweight → Equal-Weight
Sep-14-22 Initiated SVB Leerink Outperform
Sep-09-22 Initiated Morgan Stanley Underweight
Mar-03-22 Upgrade Robert W. Baird Underperform → Neutral
Dec-21-21 Downgrade Robert W. Baird Neutral → Underperform
Oct-25-21 Upgrade JP Morgan Underweight → Neutral
Sep-22-21 Downgrade Goldman Buy → Neutral
Jun-04-21 Resumed Robert W. Baird Neutral
Jan-27-21 Downgrade JP Morgan Neutral → Underweight
Jan-20-21 Reiterated H.C. Wainwright Buy
Oct-05-20 Initiated BofA Securities Buy
Sep-14-20 Upgrade Goldman Neutral → Buy
Sep-11-20 Upgrade JP Morgan Underweight → Neutral
Aug-20-20 Initiated Needham Buy
Mar-19-20 Downgrade JP Morgan Neutral → Underweight
Mar-13-20 Downgrade Goldman Buy → Neutral
Feb-27-20 Downgrade Robert W. Baird Neutral → Underperform
Feb-04-20 Downgrade JP Morgan Overweight → Neutral
Nov-14-19 Initiated Robert W. Baird Neutral
Nov-05-19 Initiated Barclays Overweight
Nov-05-19 Initiated Cowen Outperform
Nov-05-19 Initiated Goldman Buy
Nov-05-19 Initiated JP Morgan Overweight
View All

Vir Biotechnology Inc Stock (VIR) Latest News

pulisher
Oct 10, 2025

Endurance (Cayman) Ltd Svf Sells 466,242 Shares of Vir Biotechnology (NASDAQ:VIR) Stock - MarketBeat

Oct 10, 2025
pulisher
Oct 10, 2025

What institutional flow reveals about Vir Biotechnology Inc.Stop Loss & Free Weekly Watchlist of Top Performers - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Study launches of VIR-5500 combined with ARPIs in mCRPC - Urology Times

Oct 10, 2025
pulisher
Oct 09, 2025

Vir Biotechnology Announces First Patient Dosed in Part 3 of Phase 1 Trial of PSMA-Targeting PRO-XTE - PharmiWeb.com

Oct 09, 2025
pulisher
Oct 09, 2025

Vir Biotechnology announces first patient dosed in part 3 of phase 1 trial - MarketScreener

Oct 09, 2025
pulisher
Oct 09, 2025

Vir Biotechnology doses first patient in prostate cancer combo trial - Investing.com

Oct 09, 2025
pulisher
Oct 09, 2025

Vir Biotechnology (VIR) Advances Prostate Cancer Treatment with VIR-5500 Trial - GuruFocus

Oct 09, 2025
pulisher
Oct 09, 2025

Vir Biotechnology stock rises as company doses first patient in prostate cancer trial - Investing.com Canada

Oct 09, 2025
pulisher
Oct 09, 2025

Vir Biotechnology Announces First Patient Dosed in Part 3 of Phase 1 Trial of PSMA-Targeting PRO-XTEN® Dual-Masked T-Cell Engager VIR-5500 in Combination with Androgen Receptor Pathway Inhibitors for the Treatment of Metastatic Prostate Cancer - Business Wire

Oct 09, 2025
pulisher
Oct 09, 2025

Should You Allocate More Funds to DCX Systems Limited in YEARResistance Breakout Alerts & Accelerated Capital Growth - earlytimes.in

Oct 09, 2025
pulisher
Oct 09, 2025

Vir Biotechnology (VIR) Surges 6.9%: Is This an Indication of Further Gains? - Nasdaq

Oct 09, 2025
pulisher
Oct 08, 2025

Vir Biotechnology (NASDAQ:VIR) Trading Up 9.7%Here's What Happened - MarketBeat

Oct 08, 2025
pulisher
Oct 08, 2025

What analysts say about Vir Biotechnology Inc stockInsider Trading Compliance & Exceptional Return Opportunities - earlytimes.in

Oct 08, 2025
pulisher
Oct 08, 2025

Vir Biotechnology to Present Week 48 SOLSTICE Clinical Results in Hepatitis Delta at AASLD’s The Liver Meeting® 2025 - BioSpace

Oct 08, 2025
pulisher
Oct 08, 2025

Vir Biotechnology to present hepatitis delta treatment results at liver meeting - Investing.com Canada

Oct 08, 2025
pulisher
Oct 07, 2025

Vir Biotechnology (NASDAQ:VIR) Major Shareholder Sells $2,503,901.52 in Stock - MarketBeat

Oct 07, 2025
pulisher
Oct 07, 2025

Vir Biotechnology (NASDAQ:VIR) Major Shareholder Endurance (Cayman) Ltd Svf Sells 73,955 Shares - MarketBeat

Oct 07, 2025
pulisher
Oct 07, 2025

Vir Biotechnology to Present Week 48 SOLSTICE Clinical Results in Hepatitis Delta at AASLD’s The Liv - PharmiWeb.com

Oct 07, 2025
pulisher
Oct 07, 2025

Vir Biotechnology to present hepatitis delta treatment results at liver meeting By Investing.com - Investing.com South Africa

Oct 07, 2025
pulisher
Oct 07, 2025

Vir Biotechnology to Present Week 48 SOLSTICE Clinical Results in Hepatitis Delta at AASLD’s The Liver Meeting - Business Wire

Oct 07, 2025
pulisher
Oct 06, 2025

Using AI based signals to follow Vir Biotechnology Inc.Quarterly Trade Report & Verified Momentum Stock Alerts - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Price momentum metrics for Vir Biotechnology Inc. explainedWeekly Trade Analysis & Safe Entry Point Identification - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

Is Vir Biotechnology Inc. a candidate for recovery playPortfolio Value Summary & Real-Time Stock Entry Alerts - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Clarius Group LLC Purchases 560,342 Shares of Vir Biotechnology, Inc. $VIR - MarketBeat

Oct 05, 2025
pulisher
Oct 04, 2025

NKGen Biotech (NYSE:NKGN) versus AlloVir (NASDAQ:ALVR) Critical Analysis - Defense World

Oct 04, 2025
pulisher
Oct 02, 2025

Insider Sell: Vicki Sato Sells 22,000 Shares of Vir Biotechnology Inc (VIR) - GuruFocus

Oct 02, 2025
pulisher
Oct 02, 2025

Vicki Sato Sells 22,000 Shares of Vir Biotechnology (NASDAQ:VIR) Stock - MarketBeat

Oct 02, 2025
pulisher
Oct 01, 2025

KaliVir Immunotherapeutics Announces Completion of First Intravenous Patient Cohort of STEALTH-001 S - PharmiWeb.com

Oct 01, 2025
pulisher
Oct 01, 2025

Starton Therapeutics to Participate in Panel at Longwood Healthcare Leaders Boston CEO, October 27-28, 2025 - GlobeNewswire

Oct 01, 2025
pulisher
Sep 28, 2025

Can machine learning forecast Vir Biotechnology Inc. recoveryWeekly Trend Recap & High Accuracy Swing Trade Signals - newser.com

Sep 28, 2025
pulisher
Sep 28, 2025

Vir Biotechnology Shares Rise After Upgrade From BofA Securities - 富途牛牛

Sep 28, 2025
pulisher
Sep 23, 2025

Vir Biotechnology, Inc. (NASDAQ:VIR) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat

Sep 23, 2025
pulisher
Sep 21, 2025

Gains Recap: Does Vir Biotechnology Inc stock benefit from AI growth2025 Short Interest & Entry and Exit Point Strategies - خودرو بانک

Sep 21, 2025
pulisher
Sep 20, 2025

Earnings Recap: Does Vir Biotechnology Inc stock benefit from AI growth2025 Trade Ideas & High Return Trade Opportunity Guides - خودرو بانک

Sep 20, 2025
pulisher
Sep 20, 2025

Goldman Sachs Group Inc. Boosts Holdings in Vir Biotechnology, Inc. $VIR - MarketBeat

Sep 20, 2025
pulisher
Sep 20, 2025

Custom watchlist performance reports with Vir Biotechnology Inc.Weekly Trend Summary & AI Powered Market Trend Analysis - newser.com

Sep 20, 2025
pulisher
Sep 19, 2025

Fed Meeting: Is Vir Biotechnology Inc stock a smart retirement pickWeekly Stock Recap & Proven Capital Preservation Tips - خودرو بانک

Sep 19, 2025
pulisher
Sep 19, 2025

Retail Surge: Is ABRPRF stock risky to hold nowJuly 2025 Spike Watch & Fast Exit and Entry Strategy Plans - khodrobank.com

Sep 19, 2025
pulisher
Sep 19, 2025

Vir Biotechnology's (VIR) "Buy" Rating Reiterated at HC Wainwright - MarketBeat

Sep 19, 2025
pulisher
Sep 19, 2025

Vir Biotechnology (NASDAQ:VIR) Trading Down 4.7%Here's Why - MarketBeat

Sep 19, 2025
pulisher
Sep 18, 2025

Technical Analysis: What are the analyst revisions for Vir Biotechnology Inc.Is LBTYB stock a good investment in YEARMarket Rally & Stepwise Entry and Exit Trade Signals - خودرو بانک

Sep 18, 2025
pulisher
Sep 18, 2025

Aug Highlights: Is Vir Biotechnology Inc stock influenced by commodity pricesJuly 2025 Pullbacks & Low Risk Entry Point Tips - خودرو بانک

Sep 18, 2025
pulisher
Sep 18, 2025

Vir Biotechnology’s SWOT analysis: undervalued stock with potential in HDV and oncology - Investing.com Nigeria

Sep 18, 2025
pulisher
Sep 17, 2025

Aug Shorts: How cyclical is Vir Biotechnology Incs revenue streamInflation Watch & Weekly High Return Forecasts - خودرو بانک

Sep 17, 2025
pulisher
Sep 16, 2025

Returns Recap: Is Vir Biotechnology Inc. stock a smart retirement pickJuly 2025 Action & Accurate Buy Signal Alerts - خودرو بانک

Sep 16, 2025
pulisher
Sep 16, 2025

Companies Like Vir Biotechnology (NASDAQ:VIR) Could Be Quite Risky - 富途牛牛

Sep 16, 2025
pulisher
Sep 15, 2025

Aug Patterns: How cyclical is Vir Biotechnology Incs revenue streamBear Alert & Accurate Entry/Exit Alerts - khodrobank.com

Sep 15, 2025

Vir Biotechnology Inc Stock (VIR) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Vir Biotechnology Inc Stock (VIR) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
SVF Endurance (Cayman) Ltd
10% Owner
Oct 07 '25
Sale
5.60
72,133
404,154
16,087,611
SVF Endurance (Cayman) Ltd
10% Owner
Oct 03 '25
Sale
5.56
450,342
2,501,785
16,233,699
SVF Endurance (Cayman) Ltd
10% Owner
Oct 06 '25
Sale
5.69
73,955
420,641
16,159,744
$21.35
price down icon 5.74%
$83.80
price down icon 1.12%
$31.81
price down icon 0.13%
$102.06
price down icon 2.32%
$162.33
price down icon 1.26%
biotechnology ONC
$320.10
price down icon 4.68%
Cap:     |  Volume (24h):